ID   D2SC/1
AC   CVCL_U653
SY   D2SC-1
DR   Lonza; 1302
DR   Wikidata; Q54817207
RX   Patent=US6156307;
RX   PubMed=8083532;
CC   Group: Patented cell line.
CC   Transfected with: UniProtKB; P0C0N9; Avian retrovirus MH2 v-Myc.
CC   Transformant: v-Myc.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Cell type: Dendritic cell; CL=CL_0000451.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
AG   <1D
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 9
//
RX   Patent=US6156307;
RA   Granucci F.;
RT   "Immortalization of dendritic cells with v-Myc oncogene.";
RL   Patent number US6156307, 05-Dec-2000.
//
RX   PubMed=8083532; DOI=10.1016/0022-1759(94)90031-0;
RA   Lutz M.B., Granucci F., Winzler C., Marconi G., Paglia P., Foti M.,
RA   Assmann C.U., Cairns L., Rescigno M., Ricciardi-Castagnoli P.;
RT   "Retroviral immortalization of phagocytic and dendritic cell clones as
RT   a tool to investigate functional heterogeneity.";
RL   J. Immunol. Methods 174:269-279(1994).
//